Ilkay Karaoglan

Gaziantep, TR 
Gaziantep, TR 

Overview

Ilkay Karaoglan practices practicing medicine in Gaziantep, Turkey.

Their clinical expertise encompasses HIV/AIDS, Hepatitis B, Hepatitis, and Hepatitis C.

They are actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 2 clinical trials.

Locations

Gaziantep, 27850, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial For Evaluation of Efficacy and Safety of SARS-CoV-2 Vaccine (Vero Cell), Inactivated
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Biological
Study Drug: CoronaVac Vaccine
Study Phase: Phase 3
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Efficacy, Immunogenicity, and Safety of the Two-Dose Inactivated COVID-19 Vaccine (TURKOVAC) Versus the Two-Dose CoronaVac (Sinovac) Vaccine in Healthy Subjects: A Randomized, Observer-Blinded, Phase III Clinical Trial
Enrollment Status: Completed
Publish Date: February 29, 2024
Intervention Type: Biological
Study Phase: Phase 3
View 1 Less Clinical Trial

38 Total Publications

Clinical Characteristics and Predictors of One-Year Mortality in HIV and Non-HIV Patients with Cryptococcal Infections in a Middle-Income Setting: A Multicenter Cohort Study.
Clinical Characteristics and Predictors of One-Year Mortality in HIV and Non-HIV Patients with Cryptococcal Infections in a Middle-Income Setting: A Multicenter Cohort Study.
Journal: Journal of fungi (Basel, Switzerland)
Published: June 19, 2026

Frequently Asked Questions about Ilkay Karaoglan

Is Ilkay Karaoglan a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Ilkay Karaoglan is classified as an Experienced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ilkay Karaoglan participate in research or clinical trials?

Yes. Ilkay Karaoglan has published 38 articles and abstracts on conditions like HIV/AIDS. You can view a list of Ilkay Karaoglan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Karaoglan's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile